Connect Sign In
LabMind podcasts
The ARUP Clinical Investigations team includes (back row, left to right) Galina Chernova, Kendall Ence, Qian Guo, Stephanie Harrison, and Jacob Brugger; (middle row, left to right) Nicholas Mangome, Chau Trinh, Ani Schjelderup, Carrie Pederson, and Amy Ballard; (front row, left to right) Toni Pollock, Katharina Pennington, Karis Tran, and Rachel Lloyd. |
August 4, 2025 |
ARUP’s Central Pathology Review Service Supports Cogent Biosciences SUMMIT Trial ARUP’s central pathology review service has provided key support for the Cogent SUMMIT trial through robust laboratory testing, mastocytosis pathology expertise, and rigorous quality standards. |
Hepatitis delta virus (HDV), which affects an estimated 48 to 72 million people worldwide, results in the most severe form of viral hepatitis-induced liver disease. |
July 31, 2025 |
ARUP-Validated Assay for Hepatitis D Virus Increases Sensitivity 15-Fold ARUP has launched a highly sensitive and fully automated molecular assay to detect hepatitis delta virus (HDV) that will facilitate better detection of the virus. |
ARUP medical directors will discuss our newly expanded test menu based on the latest research, guidelines, and technology. |
July 23, 2025 |
ARUP Experts To Share Laboratory Medicine Research at AAIC and ADLM Conferences At upcoming conferences, ARUP experts will highlight a new blood-based biomarker assay for Alzheimer’s disease and share a presentation on building a successful laboratory outreach program. |
ARUP’s validation of a plasma-based immunoassay to detect Alzheimer’s disease pathology was selected as a 2025 Academy Distinguished Abstract. Nicholas Spies, MD, received the 2025 Outstanding Scientific Achievements by a Young Investigator Merit Award. |
July 21, 2025 |
The Association for Diagnostics and Laboratory Medicine To Recognize ARUP Achievements at ADLM 2025 ARUP experts have received recognition from ADLM and the ADLM Academy for their remarkable achievements this year, winning Young Investigator Merit and Distinguished Abstracts awards. |
Sherin Shaaban, MD, PhD, MSci, FACMG, ARUP medical director of Pharmacogenomics and Molecular Genetics, is the expert overseeing two ARUP tests that detect nine well-studied variants of DPYD. |
July 16, 2025 |
Genetic Testing Gains Ground: DPYD Genotyping Can Be a Lifesaving Step Before Chemotherapy A patient’s insistence on DPYD genotyping before chemotherapy highlights growing support for broader testing to prevent severe or fatal drug toxicity in patients. |
Kristi Smock, MD, ARUP Laboratories vice president and chief medical director of Research and Development, has been chosen for the esteemed Executive Leadership in Academic Medicine (ELAM) program. “She is one of the brightest, upcoming stars we have at ARUP, and I’m certain she will excel in this program,” said Andy Theurer, CEO. |
June 23, 2025 | Kristi Smock, MD, was selected to join the Executive Leadership in Academic Medicine (ELAM) program to hone her leadership skills and make impactful contributions to academic medicine. |
ARUP Institute for Research and Innovation in Diagnostic and Precision Medicine™ We accelerate the development and adoption of cutting-edge diagnostic and prognostic technologies advancing patient care through groundbreaking science and engineering. The Sherrie Perkins Research and Innovation Collaboration Grant The Sherrie Perkins Research and Innovation Collaboration Grant funds cutting-edge research in laboratory medicine.
ARUP Newsroom
Live Chat